PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.13) by 46.15 percent. This is a 92.93 percent increase over losses of $(0.99) per share from the same period last year. The company reported quarterly sales of $8.00 thousand which missed the analyst consensus estimate of $10.00 thousand by 20.00 percent. This is a 99.21 percent decrease over sales of $1.01 million the same period last year.